Metallothioneins as dynamic markers for brain disease in lysosomal disorders

OBJECTIVE: To facilitate development of novel disease-modifying therapies for lysosomal storage disorder (LSDs) characterized by nervous system involvement such as metachromatic leukodystrophy (MLD), molecular markers for monitoring disease progression and therapeutic response are needed. To this en...

Descripción completa

Detalles Bibliográficos
Autores principales: Cesani, Martina, Cavalca, Eleonora, Macco, Romina, Leoncini, Giuseppe, Terreni, Maria Rosa, Lorioli, Laura, Furlan, Roberto, Comi, Giancarlo, Doglioni, Claudio, Zacchetti, Daniele, Sessa, Maria, Scherzer, Clemens R, Biffi, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237725/
https://www.ncbi.nlm.nih.gov/pubmed/24242821
http://dx.doi.org/10.1002/ana.24053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237725/
https://www.ncbi.nlm.nih.gov/pubmed/24242821
http://dx.doi.org/10.1002/ana.24053

Ejemplares similares